.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

DOVONEX Drug Profile

« Back to Dashboard
Dovonex is a drug marketed by Leo Pharm and Leo Pharma As and is included in three NDAs. It is available from four suppliers.

The generic ingredient in DOVONEX is calcipotriene. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the calcipotriene profile page.

Summary for Tradename: DOVONEX

Patents:0
Applicants:2
NDAs:3
Suppliers / Packagers: see list4
Drug Prices: :see details

Pharmacology for Tradename: DOVONEX

Ingredient-typeVitamin D
Drug ClassVitamin D Analog
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leo Pharm
DOVONEX
calcipotriene
SOLUTION;TOPICAL020611-001Mar 3, 1997DISCNNo► subscribe► subscribe
Leo Pharma As
DOVONEX
calcipotriene
CREAM;TOPICAL020554-001Jul 22, 1996RXYes► subscribe► subscribe
Leo Pharma As
DOVONEX
calcipotriene
OINTMENT;TOPICAL020273-001Dec 29, 1993DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DOVONEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leo Pharm
DOVONEX
calcipotriene
SOLUTION;TOPICAL020611-001Mar 3, 19974,866,048► subscribe
Leo Pharma As
DOVONEX
calcipotriene
CREAM;TOPICAL020554-001Jul 22, 19965,763,426► subscribe
Leo Pharma As
DOVONEX
calcipotriene
OINTMENT;TOPICAL020273-001Dec 29, 19934,866,048► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: DOVONEX

Drugname Dosage Strength RLD Submissiondate
calcipotrieneTopical Cream0.005%Dovonex`12/2/2009
calcipotrieneTopical Solution0.01%Dovonex5/19/2006
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc